Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapineLEHR, Thorsten; JING YUAN; HALL, David et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 11, pp 721-730, issn 1744-6872, 10 p.Article

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descentJING YUAN; SHENG GUO; PODZAMCZER, Daniel et al.AIDS (London). 2011, Vol 25, Num 10, pp 1271-1280, issn 0269-9370, 10 p.Article

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium : The predictive safety testing consortiumDIETERLE, Frank; SISTARE, Frank; SULTANA, Stefan et al.Nature biotechnology (Print). 2010, Vol 28, Num 5, pp 455-462, issn 1087-0156, 8 p.Article

Gene expression analysis reveals chemical-specific profilesHAMADEH, Hisham K; BUSHEL, Pierre R; BLANCHARD, Kerry et al.Toxicological sciences (Print). 2002, Vol 67, Num 2, pp 219-231, issn 1096-6080Article

Methapyrilene toxicity: Anchorage of pathologic observations to gene expression alterationsHAMADEH, Hisham K; KNIGHT, Brian L; CUNNINGHAM, Michael L et al.Toxicologic pathology. 2002, Vol 30, Num 4, pp 470-482, issn 0192-6233Article

Assessment of cisplatin-induced nephrotoxicity by microarray technologyQIHONG HUANG; DUNN, Robert T; JAYADEV, Supriya et al.Toxicological sciences (Print). 2001, Vol 63, Num 2, pp 196-207, issn 1096-6080Article